Today. After 4PM:

Today. After 5PM:

Notice how low testing has gotten (in spite of high positivity, about 1 in 10):

No tests -> no cases -> no problem? Even when deaths are up sharply?

The new data:

Data pre-COVID/Wuhan virus:

Just published:

Description:

WHO and YT

https://www.who.int/teams/digital-health-and-innovation/digital-channels/combatting-misinformation-online

WHO works with social media policy departments to ensure company policy and guidelines for content providers are fit for purpose.

John’s e mail

enquiries@drjohncampbell.co.uk

https://www.who.int/campaigns/connecting-the-world-to-combat-coronavirus/how-to-report-misinformation-online

WHO provide a helpful guide on how to report misinformation online

Inaccurate information spreads widely and at speed,

making it more difficult for the public to identify verified facts and advice from trusted sources, such as their local health authority or WHO.

https://support.google.com/youtube/answer/9795167?hl=en

As a starting point in the UK, only NHS organisations are being invited to self-certify against the NHS Standard for Creating Health Content.

By completing the self-certification process, an NHS organisation channel will be eligible for information panels indicating NHS credibility.

From FDA to MHRA: are drug regulators for hire?

https://www.bmj.com/content/377/bmj.o1538.full

Regulatory agencies, large proportions of their budgets,

funded by the industry they are sworn to regulate

US Food and Drug Administration (FDA)

1992, Prescription Drug User Fee Act, allowing industry to fund the US Food and Drug Administration (FDA) directly through “user fees”

Net PDUFA fees collected

$29m in 1993

$884m in 2016 (65% of budget)

FDA, 9 out of 10 of its past commissioners between 2006 and 2019 went on to secure roles linked with pharmaceutical companies

European Medicines Agency (EMA)

Industry fees funded 20% European Medicines Agency (EMA), in 1995

By 2010, 75%

Today, 89%

Medicines and Healthcare Products Regulatory Agency (MHRA)

86% of funding from Pharmaceutical Industry

Australia

https://www.tga.gov.au

Proportion of TGA budget derived from industry, 96%

WHO funding

https://app.powerbi.com/view?r=eyJrIjoiNzNmNTRkMWEtNmZjMS00NzdjLWEyMDYtYWExYzA4NzVhZGQwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9

https://www.weforum.org/agenda/2020/04/who-funds-world-health-organization-un-coronavirus-pandemic-covid-trump/

The second-largest funder is the Bill and Melinda Gates Foundation, which provides 9.8% of the WHO’s funds

Appendix

https://genius.com/George-orwell-nineteen-eighty-four-appendix-the-principles-of-newspeak-annotated

https://www.orwell.ru/library/novels/1984/english/en_app

It was expected that Newspeak would have finally superseded Oldspeak (or Standard English, as we should call it) by about the year 2050

The purpose of Newspeak was not only to provide a medium of expression for the world-view and mental habits proper to the devotees of Ingsoc, but to make all other modes of thought impossible.

The C vocabulary was supplementary to the others and consisted entirely of scientific and technical terms. These resembled the scientific terms in use today, and were constructed from the same roots, but the usual care was taken to define them rigidly and strip them of undesirable meanings.

War is peace, freedom is slavery, ignorance is strength

Next Monday, 14th November, evidence based medicine confrence

https://www.eventbrite.co.uk/e/has-big-pharma-hijacked-evidence-based-medicine-tickets-444525075467

Covid infection did not increase incidence of post-covid myocarditis or pericarditis.

The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients-A Large Population-Based Study

https://pubmed.ncbi.nlm.nih.gov/35456309/

https://www.mdpi.com/journal/jcm

Myocarditis and pericarditis, post-acute cardiac sequelae of COVID-19 infection,

arising from adaptive immune responses.

? incidence

Retrospective cohort study

Study group, had infection

N = 196,992 adults after COVID-19 infection

(Clalit Health Services)

March 2020 to January 2021

Inpatient myocarditis and pericarditis diagnoses,

from day 10 after positive PCR

Israeli vaccination program initiated on 20 December 2020

Follow-up was censored on 28 February 2021

Control cohort, never infected

N = 590,976 adults,

with at least one negative PCR and no positive PCR

(age- and sex-matched)

Calculated backward from 15 December 2020

Results

Post-COVID-19 group

Nine post-COVID-19 patients developed myocarditis (0.0046%)

Eleven diagnosed with pericarditis (0.0056%)

Control group, never covid infected

27 developed myocarditis (0.0046%) P = 1

52 developed pericarditis (0.0088%) P = 0.17

Adjusted hazard ratio [aHR]

Myocarditis, male (aHR 4.42) regardless of previous COVID-19 infection

Pericarditis, (aHR 1.93)

Peripheral vascular disease, (aHR 4.20)

Follow up

Median, 4.1 months

Covid cohort, 700,040 person-months

Non covid cohort, 2,100,077 person-months

Conclusions

Post COVID-19 infection was not associated with myocarditis (aHR 1.08)

Post COVID-19 infection was not associated with pericarditis (aHR 0.53)

We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.

Our data suggest that there is no increase in the incidence of myocarditis and pericarditis in COVID-19 recovered patients,

compared to uninfected matched controls.

Hungary is ranked 3^rd in the world for COVID-19 deaths/capita:

Description:

ONS, 1st November release, UK deaths, week ending 21 October 2022

13,463

15.7%

1,822 excess deaths

Deaths involving COVID-19, 5.5% of all UK deaths

https://www.bhf.org.uk/-/media/files/what-we-do/influencing-change/tipping-point-bhf-report.pdf?rev=089147572a2c4dd789746b5e6f4ba617&hash=F7141D4C13A10C6C089824892CA59CDE

https://hansard.parliament.uk/commons/2022-10-24/debates/FF880636-BC3B-4BDB-A5E0-D6D4B82B2888/Covid-19VaccinesSafety

Mr. Andrew Bridgen MP (NW Leicestershire)

https://www.youtube.com/watch?v=pfgGCgxGYkk

Eurostat

https://ec.europa.eu/eurostat/databrowser/view/demo_mexrt/default/table?lang=en

https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Map01_Excess_Mortality_2022_Aug.png

Latest from Dr. John Campbell:

Covid antibodies found in stored blood samples

Milan Institute for Tumour Diseases, Coronavirus antibodies, September, 2019

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy (October 2021)

https://pubmed.ncbi.nlm.nih.gov/33176598/

Full text version

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529295/

Screening and Multiple Intervention on Lung Epidemics (SMILE

https://clinicaltrials.gov/ct2/show/NCT03654105

There are no robust data, coronavirus 2 (SARS-CoV-2) infection and spread, prepandemic period worldwide

We investigated the presence of SARS-CoV-2 receptor-binding domain (RBD)-specific antibodies

Blood samples of 959 asymptomatic individuals,

enrolled in a prospective lung cancer screening trial,

between September 2019 and March 2020

Plasma samples repository

Results

SARS-CoV-2 RBD-specific antibodies were detected in,

111 of 959 (11.6%) individuals

All the patients were asymptomatic at the time of blood sample collection.

Actual timeframe

First positive test, 3rd September

September 2019 23/162 (14.2%)

October 2019 27/166 (16.3%)

Second week of February 2020, (more than 30%)

By the end of September, Lombardy, Veneto, Piedmont, Emilia Romagna, Liguria, Lazio, Campania, Friuli.

Official timeframe

End of December 2019, coronavirus 2 identified in Wuhan, Hubei Province, China

January 30th 2020 Italy’s first two cases,

(two tourists from China tested positive in Rome)

February 20, 2020 Lombardy, 38-year-old man, no history of travel

Authors

This study shows an unexpected very early circulation of SARS-CoV-2 among asymptomatic individuals

Several months before the first patient was identified

Finding SARS-CoV-2 antibodies in asymptomatic people before the COVID-19 outbreak in Italy may reshape the history of pandemic.

Phenomena 1

Underestimation of prevalence

Swabs and serology, focused on symptomatic cases

Therefore, an underestimation of overall COVID-19 infections

(Selection bias)

Therefore overestimation of mortality rate

May 25 and July 15 (2020)

SARS-CoV-2 seroprevalence study, n = 64,660

Prevalence rate was 2.5%

Approximately 1.5 million, (many of whom were asymptomatic)

Estimate almost 5 times higher than official reports

Phenomena 2

Onset of the epidemic, likely to have preceded identification of the first case

November–December 2019

Doctors reporting, severe respiratory symptoms in elderly and frail,

with atypical bilateral bronchitis,

which was attributed to aggressive forms of seasonal influenza

Based on these findings, a prior unnoticed circulation of the virus among the Italian population could be hypothesized.

October 2019 to February 2020

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428442/

Molecular analysis, PCR, 40 wastewater samples Milan/Lombardy, Turin/Piedmont, and Bologna/Emilia Romagna)

Presence of viral RNA,

December 18th in Milan and Turin

So, in which direction did the virus travel?

7th Military World Games

??????????

Commonly known as Wuhan 2019

October 18–27, 2019

Around 230,000 volunteers

9,308 athletes from 109 countries competing in 329 events